Publicaciones en colaboración con investigadores/as de Helmholtz Zentrum München (27)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

2021

  1. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 6, pp. 1640-1660

2020

  1. A compendium answering 150 questions on COVID-19 and SARS-CoV-2

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 10, pp. 2503-2541

  2. Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie

    Allergologie, Vol. 43, Núm. 7, pp. 255-271

  3. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 10, pp. 2445-2476

  4. In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 9, pp. 2161-2169

  5. State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 4, pp. 746-760

2019

  1. Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body

    Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19

  2. Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

    Blood, Vol. 134, Núm. 3, pp. 263-276

  3. Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 11, pp. 2064-2076

2018

  1. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

    Redox Biology

  2. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

    Neuron, Vol. 97, Núm. 6, pp. 1268-1283.e6

  3. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

    Allergo Journal International, Vol. 27, Núm. 8, pp. 245-255

2017

  1. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    Redox Biology, Vol. 13, pp. 94-162

  2. Live imaging followed by single cell tracking to monitor cell biology and the lineage progression of multiple neural populations

    Journal of Visualized Experiments, Vol. 2017, Núm. 130

2016

  1. Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming

    Cell Stem Cell, Vol. 18, Núm. 3, pp. 396-409

  2. Immunophenotyping pattern characterization in canine blood: Towards a clinical application

    Acta Veterinaria Brno, Vol. 85, Núm. 2, pp. 139-145

  3. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Nature Genetics, Vol. 48, Núm. 9, pp. 1037-1042

2015

  1. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, Núm. 7, pp. 727-754